Man Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Hold
0
1718
2020
Q1
Sell
-9,080
Closed -$342K 1647
2019
Q4
$342K Buy
+9,080
New +$408K ﹤0.01% 1647
2019
Q3
Sell
-5,167
Closed -$270K 1797
2019
Q2
$270K Sell
5,167
-7,100
-58% -$416K ﹤0.01% 1764
2019
Q1
$846K Buy
+12,267
New +$822K ﹤0.01% 1624
2018
Q3
Sell
-3,978
Closed -$502K 2098
2018
Q2
$502K Buy
+3,978
New +$484K ﹤0.01% 1808

Other funds holding CLB

Man Group's CLB Position: Q1 2023 in Review

Man Group held its Core Laboratories (CLB) position steady in Q1 2023 at 0 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Man Group first reported a position in CLB in Q2 2018 and has held it in 4 quarters since. The position peaked at $846K in Q1 2019. 163 funds tracked by Wall St. Rank hold CLB as of Q1 2023.

  • Man Group held 0 shares of Core Laboratories worth $271K as of Q1 2023.
  • Man Group left its Core Laboratories share count unchanged in Q1 2023.
  • Core Laboratories made up ﹤0.01% of Man Group's portfolio in Q1 2023, its #1718 holding.
  • Man Group first reported a position in Core Laboratories in Q2 2018 and has held it in 4 quarters since.
  • Man Group's Core Laboratories position peaked at $846K in Q1 2019.
  • 163 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.